
Big Pharma markets left on a ‘patent cliff’-hanger
FT News Briefing
00:00
Navigating the Intersection of Shareholder Lawsuits and Patent Challenges in Pharma
This chapter examines the intricacies of shareholder lawsuits and their varying impacts on companies incorporated in Delaware and Nevada. It also addresses the pharmaceutical sector's struggles with patent expirations, emphasizing the challenges faced by major players like Merck.
Transcript
Play full episode